Investors
Scancell Holdings PLC is an AIM listed company
Latest News
Scancell to present translational data from the Phase 2 ongoing SCOPE trial of SCIB1 at the 2025 AACR IO conference
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Interim Results for the six months ended 31 October 2024
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!